MedPath

Solvotrin Innovations Ltd.

🇮🇪Ireland
Ownership
Private
Employees
-
Market Cap
-
Website

A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects

Not Applicable
Conditions
Iron Adverse Reaction
Iron Deficiency Anemia
Premenopause
Iron-deficiency
Heavy Menstrual Bleeding
Interventions
Dietary Supplement: Ferrous sulfate 14mg once daily
Dietary Supplement: Ferrous sulfate 25mg twice daily
Dietary Supplement: Ferrous sulfate 25mg once daily
First Posted Date
2021-03-02
Last Posted Date
2021-03-26
Lead Sponsor
Solvotrin Innovations Ltd
Target Recruit Count
60
Registration Number
NCT04778072
Locations
🇮🇪

Atlantia Clinical Trials, Cork, Co Cork, Ireland

© Copyright 2025. All Rights Reserved by MedPath